The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

43 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
21
Design and Synthesis of a Series of l-trans-4-Substituted Prolines as Selective Antagonists for the Ionotropic Glutamate Receptors Including Functional and X-ray Crystallographic Studies of New Subtype Selective Kainic Acid Receptor Subtype 1 (GluK1) Antagonist (2S,4R)-4-(2-Carboxyphenoxy)pyrrolidinEBI
Mcgill University
14
Design, synthesis and structure-activity relationships of novel phenylalanine-based amino acids as kainate receptors ligands.EBI
Jagiellonian University Medical College
1
A monocyclic neodysiherbaine analog: Synthesis and evaluation.EBI
Yokohama City University
6
Tweaking Subtype Selectivity and Agonist Efficacy at (S)-2-Amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propionic acid (AMPA) Receptors in a Small Series of BnTetAMPA Analogues.EBI
University of Copenhagen
18
Studies on Aryl-Substituted Phenylalanines: Synthesis, Activity, and Different Binding Modes at AMPA Receptors.EBI
University of Copenhagen
4
Structural studies, homology modeling and molecular docking of novel non-competitive antagonists of GluK1/GluK2 receptors.EBI
Medical University of Lublin
39
Ion channels as therapeutic targets: a drug discovery perspective.EBI
Pfizer
18
Chemoenzymatic synthesis of new 2,4-syn-functionalized (S)-glutamate analogues and structure-activity relationship studies at ionotropic glutamate receptors and excitatory amino acid transporters.EBI
University of Copenhagen
4
4-hydroxy-1,2,5-oxadiazol-3-yl moiety as bioisoster of the carboxy function. Synthesis, ionization constants, and molecular pharmacological characterization at ionotropic glutamate receptors of compounds related to glutamate and its homologues.EBI
University of Turin
5
The glutamate receptor GluR5 agonist (S)-2-amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid and the 8-methyl analogue: synthesis, molecular pharmacology, and biostructural characterization.EBI
University of Copenhagen
20
1H-cyclopentapyrimidine-2,4(1H,3H)-dione-related ionotropic glutamate receptors ligands. structure-activity relationships and identification of potent and Selective iGluR5 modulators.EBI
European Research Centre For Drug Discovery and Development (Natsyndrugs)
11
Chemo-enzymatic synthesis of a series of 2,4-syn-functionalized (S)-glutamate analogues: new insight into the structure-activity relation of ionotropic glutamate receptor subtypes 5, 6, and 7.EBI
Universite Blaise Pascal
13
Chemo-enzymatic synthesis of (2S,4R)-2-amino-4-(3-(2,2-diphenylethylamino)-3-oxopropyl)pentanedioic acid: a novel selective inhibitor of human excitatory amino acid transporter subtype 2.EBI
Universite Blaise Pascal
2
Structures of the ligand-binding core of iGluR2 in complex with the agonists (R)- and (S)-2-amino-3-(4-hydroxy-1,2,5-thiadiazol-3-yl)propionic acid explain their unusual equipotency.EBI
University of Copenhagen
6
Synthesis and pharmacological characterization at glutamate receptors of the four enantiopure isomers of tricholomic acid.EBI
University of Milan
15
Synthesis and pharmacological characterization of N3-substituted willardiine derivatives: role of the substituent at the 5-position of the uracil ring in the development of highly potent and selective GLUK5 kainate receptor antagonists.EBI
University Walk
18
Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors.EBI
University Walk
3
Ethyl (3S,4aR,6S,8aR)-6-(4-ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso-quinoline-3-carboxylic ester: a prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine.EBI
Eli Lilly
27
4-Alkylidenyl glutamic acids, potent and selective GluR5 agonists.EBI
Eli Lilly
25
Piperazine-2,3-dicarboxylic acid derivatives as dual antagonists of NMDA and GluK1-containing kainate receptors.EBI
University of Bristol
11
Selective kainate receptor (GluK1) ligands structurally based upon 1H-cyclopentapyrimidin-2,4(1H,3H)-dione: synthesis, molecular modeling, and pharmacological and biostructural characterization.EBI
University of Copenhagen
4
Biostructural and Pharmacological Studies of Bicyclic Analogues of the 3-Isoxazolol Glutamate Receptor Agonist Ibotenic AcidEBI
TBA
2
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.EBI
Novartis Pharma
26
Domoic Acid as a Lead for the Discovery of the First Selective Ligand for Kainate Receptor Subtype 5 (GluK5).EBI
University of Copenhagen
6
A tetrazolyl-substituted subtype-selective AMPA receptor agonist.EBI
University of Copenhagen
14
Structure-activity relationship studies on N3-substituted willardiine derivatives acting as AMPA or kainate receptor antagonists.EBI
University Walk
7
Two prodrugs of potent and selective GluR5 kainate receptor antagonists actives in three animal models of pain.EBI
Eli Lilly
7
Convergent synthesis and pharmacology of substituted tetrazolyl-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid analogues.EBI
The Danish University of Pharmaceutical Sciences
147
Functionalized quinoxalinones as privileged structures with broad-ranging pharmacological activities.EBI
Central South University
20
Bioisosteric modifications of 2-arylureidobenzoic acids: selective noncompetitive antagonists for the homomeric kainate receptor subtype GluR5.EBI
The Danish University of Pharmaceutical Sciences
48
2-arylureidobenzoic acids: selective noncompetitive antagonists for the homomeric kainate receptor subtype GluR5.EBI
The Danish University of Pharmaceutical Sciences
3
Design, synthesis, and pharmacology of a highly subtype-selective GluR1/2 agonist, (RS)-2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid (Cl-HIBO).EBI
The Danish University of Pharmaceutical Sciences
11
Pyrrolylquinoxalinediones carrying a piperazine residue represent highly potent and selective ligands to the homomeric kainate receptor GluR5.EBI
Abbott
46
4-Alkyl- and 4-cinnamylglutamic acid analogues are potent GluR5 kainate receptor agonists.EBI
Eli Lilly
36
Synthesis of a series of aryl kainic acid analogs and evaluation in cells stably expressing the kainate receptor humGluR6.EBI
Eli Lilly
2
Allosteric control of an ionotropic glutamate receptor with an optical switch.EBI
University of California Berkeley
5
( S)-2-Amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic Acid (AMPA) and Kainate Receptor Ligands: Further Exploration of Bioisosteric Replacements and Structural and Biological Investigation.EBI
University of Siena
10
Augmentation of Anticancer Drug Efficacy in Murine Hepatocellular Carcinoma Cells by a Peripherally Acting Competitive N-Methyl-d-aspartate (NMDA) Receptor Antagonist.EBI
University of Eastern Finland
2
Compounds as rearranged during transfection (RET) inhibitorsBDB
Glaxosmithkline
10
Molecular design and biological activity of potent and selective protein kinase inhibitors related to balanol.BDB
University of California San Diego
11
Achiral oligoamines as versatile tool for the development of aspartic protease inhibitors.BDB
Philipps University Marburg
37
Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.BDB
Kochi Medical School